| Name | Title | Contact Details |
|---|
In 2011, Viva Naturals was founded by a team of people who didn`t just know a lot about wellness—they made it their way of life. And nothing has changed since: from the reception desk to the boardroom, everyone at Viva believes in the power of healthy living (and the power of a good laugh, because it`s not healthy to take yourself too seriously). As wellness enthusiasts, we take pride in putting out the caliber of product we`d want for ourselves.
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.
As an integrated, not-for-profit organization, CentraCare is working to improve the lives and wellbeing of those living in Central Minnesota. CentraCare provides care through hospitals located in St. Cloud, Long Prairie, Melrose, Monticello, Paynesville and Sauk Centre with more than 25 clinics and specialty centers throughout the region. Additionally, Carris Health, a wholly-owned subsidiary of CentraCare, is comprised of Rice Memorial Hospital in Willmar, Redwood Hospital in Redwood Falls and seven clinics in the Southwest and West Central region of the state. CentraCare – St. Cloud Hospital has been a Magnet-designated hospital since 2004 and repeatedly receives national recognition for its outstanding quality measures. CentraCare provides comprehensive primary through tertiary care, CentraCare also operates numerous specialty services, including the CentraCare Heart & Vascular Center, Coborn Cancer Center and the CentraCare Kidney Program. CentraCare serves all who seek care with compassion, dignity and respect, while seeking to enhance individual and community health. Mission: CentraCare Health works to improve the health of every patient, every day. Vision: CentraCare Health will be the leader in Minnesota for quality, safety, service and value. Core Values: •Patient Centered: Serving patients above all. •Integrity: Adhering to honest and ethical practices. •Collaboration: Working jointly with others to improve health and health care. •Compassion: Serving all who seek our care with kindness, dignity, and respect. •Stewardship: Ensuring responsible use of all resources to best serve our communities.
Meta Dental Co is a Elmhurst, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.